There are currently restrictions on flights to Iguazu along with the rest of Argentina. Before you book or search for flights, consider the following restrictions: Entry restrictions
Argentina has restricted entry to most foreign travelers, except for nationals and residents, and repatriation, medical, and humanitarian flights.
Argentina suspended international passenger flights from the pandemic "affected areas" (Europe, the US, South Korea, Japan, China, and Iran) until at least November 8.
With effect from October 30, nationals and residents of Bolivia, Brazil, Chile, Paraguay and Uruguay can enter Argentina to visit the Metropolitan Area of Buenos Aires for tourism purposes. Entry will only be allowed through the Port of Buenos Aires (Buquebus Terminal) and through Ezeiza International Airport in the Province of Buenos Aires. Traveling to other provinces is not allowed yet.
Airlines operating repatriation flights must send all passenger information to ANAC 12 hours before departure. This information must contain the passenger list with travel document numbers, phone numbers, and addresses where each person declares that they will comply with the mandatory quarantine upon arrival.
Passengers must complete a "Declaración Jurada Electrónica para el ingreso al Territorio Nacional".
All travelers must have a medical certificate with a negative COVID-19 PCR test result issued within 72 hours prior to arrival and a medical insurance with coverage of COVID-19 treatment cost. Children under the age of 6 are exempt from these requirements
Starting on December 15, all travelers arriving in Buenos Aires City via Ezeiza Airport may be subject to COVID-19 testing in lieu of quarantine.
All travelers authorized to enter the country and have a valid medical certificate with a negative COVID-19 PCR test result are not subject to 10-day self isolation upon arrival.
If you are looking to book a trip to Iguazu and are outside of the restricted areas, please take the proper precautions and stay informed about traveling during COVID-19.